Kekulai
Copy email

Innovating at the intersection of AI and small molecule drug discovery

Black molecule image
Red pattern gradient background image

Investors

General Catalyst
Amplify
Sunflower Capital

Partners

Nvidia Inception Program
Microsoft for Startups
Our Team
Glow effect image
Photo of Hannah Shen, PhD
Hannah Shen, PhD
Cofounder & CEO
  • Company Scaler: built and scaled biotech (BridgeBio) and computation-first companies (Octant, Benchling).
  • Pipeline Strategist: incubated and launched high-value programs including GondolaBio ($300M), PORT-77 (Phase 2), and Encaleret (Phase 3).
Glow effect image
Photo of Chaya Stern, PhD
Chaya Stern, PhD
Founding Head of Computational Chemistry
  • Builder + User: fluency in building AI platforms (DeepCure) and driving drug programs (Odyssey).
  • Rapid Iterator: expert in blending open-source and proprietary tools to shorten design-make-test cycles.
Glow effect image
Photo of Ching-Yi Lin
Ching-Yi Lin
Founding Head of Engineering
  • 0-to-1 Builder: founding engineer who shipped and scaled AI-native applications from the ground up.
  • Cloud Architect: built enterprise-grade, cloud-native infrastructure required for high throughput AI workloads.
Red pattern gradient background image

Contact us

hello@kekulai.com
Copy email